Computer- aided biopharmaceutical characterization: gastrointestinal absorption simulation - Computer-Aided Applications in Pharmaceutical Technology - page 229

Pharmacokinetics and protein binding of gliclazide'. J. Pharm. Dyn. , 4(6):
436-42.
Kocic, I., Homsek, I., Dacevic, M., Grbic, S., Parojcic, J., et al. (2012) 'A case
study on the in silico absorption simulations of levothyroxine sodium
immediate-release tablets', Biopharm. Drug Dispos. , 33(3): 146-59.
Kovacevic, I., Parojcic, J., Homsek, I., Tubic-Grozdanis, M., and Langguth, P.
(2009) 'Justifi cation of biowaiver for carbamazepine, a low soluble high
permeable compound, in solid dosage forms based on IVIVC and
gastrointestinal simulation', Mol. Pharm. , 6(1): 40-7.
Kuentz, M. (2008) 'Drug absorption modeling as a tool to defi ne the strategy in
clinical formulation development', AAPS J. , 10(3): 473-9.
Kuentz, M., Nick, S., Parrott, N., and Röthlisberger, D. (2006) 'A strategy for
preclinical formulation development using GastroPlus as pharmacokinetic
simulation tool and a statistical screening design applied to a dog study', Eur.
J. Pharm. Sci. , 27(1): 91-9.
Lave, T. , Parrott, N., Grimm, H.P., Fleury, A., and Reddy, M. (2007) 'Challenges
and opportunities with modelling and simulation in drug discovery and drug
development', Xenobiotica , 37(10-11): 1295-310.
Mahar Doan, K.M. and Boje, K.M.K. (2000) 'Theoretical pharmacokinetic and
pharmacodynamic simulations of drug delivery mediated by blood-brain
barrier transporters', Biopharm. Drug Dispos. , 21(7): 261-78.
Marques, M. (2004) 'Dissolution media simulating fasted and fed states',
Dissolut. Technol. , 11(2): 16.
Mueller, E.A., Kovarik, J.M., van Bree, J.B., Grevel, J., Lücker, P. W. , and Kutz, K.
(1994) 'Infl uence of a fat-rich meal on the pharmacokinetics of a new oral
formulation of cyclosporine in a crossover comparison with the market
formulation', Pharm. Res. , 11(1): 151-5.
Najib, N., Idkaidek, N., Beshtawi, M., Bader, M., Admour, I., et al. (2002)
'Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide®
& Diamicron®) in healthy human volunteers', Biopharm. Drug Dispos. ,
23(5): 197-202.
Norris, D.A., Leesman, G.D., Sinko, P.J., and Grass, G.M. (2000) 'Development
of predictive pharmacokinetic simulation models for drug discovery', J.
Control Release , 65(1-2): 55-62.
Okumu, A., DiMaso, M., and Löbenberg, R. (2008) 'Dynamic dissolution testing
to establish in vitro / in vivo correlations for montelukast sodium, a poorly
soluble drug', Pharm. Res. , 25(12): 2778-85.
Okumu, A., DiMaso, M., and Löbenberg, R. (2009) 'Computer simulations
using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug
products', Eur. J. Pharm. Biopharm. , 72(1): 91-8.
Parojcˇic´ , J., Stojkovic´ , A., Tajber, L., Grbic´ , S., Paluch, K.J., et al. (2011)
'Biopharmaceutical characterization of ciprofl oxacin HCl-ferrous sulfate
interaction', J. Pharm. Sci. , 100(12): 5174-84.
Parrott, N. and Lave, T. (2002) 'Prediction of intestinal absorption: comparative
assessment of GastroPlus™ and IDEA™', Eur. J. Pharm. Sci. , 17(1-2):
51-61.
Parrott, N. and Lave, T.

￿

￿ ￿

(2008) 'Applications of physiologically based absorption
models in drug discovery and development', Mol. Pharm. , 5(5): 760-75.